ContextVision presents Q2 2009 report.

Report this content

Jan Erik Hedborg, the company´s CEO, commented: The second quarters major highlight was the signing of an agreement with a global OEM for the implementation of our inter-ventional radiology imaging software, GOPView® iRVPlus. The global manufacturer of interventional radiology equipment will launch its stationary interventional radiology machines with our image enhancement software later this year. This latest agreement is a breakthrough into the fixed C-arm market. Taken together with the earlier announced agreement in 2008 with one of the major mobile C-arm manufacturers, the agreements strengthen ContextVison market position within this imaging modality. In both cases, revenues will start in Q4 2009 and the revenue contribution from GOPView iRVPlus will strengthen our financial results in 2010. Despite the challenging circumstances of weaker sales and profit in first half of the year, we are confident in our future and our ability to maintain our technological lead within the medical imaging enhancement market. We expect to benefit significantly once hospitals and caregivers return to more normalized capital equipment purchasing patterns. Our recent as well as expected new product launches will bring ContextVision back on the growth plan.

Subscribe

Documents & Links